{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:44:40Z","timestamp":1794314680182,"version":"4.9.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Surgical aortic valve replacement (SAVR) is the commonly used approach for aortic valve replacement (AVR) in patients with aortic stenosis at low or intermediate surgical risk. However, transcatheter aortic valve replacement (TAVR) has emerged as an alternative to SAVR for AVR. This meta-analysis aims to assess the comparative efficacy and safety of TAVR versus SAVR in low-to-intermediate surgical risk patients by analyzing temporal trends in the outcomes of TAVR and SAVR at various follow-up intervals, providing a more detailed understanding.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A thorough literature search was performed across PubMed\/MEDLINE, Embase, and the Cochrane Library from their inception up to May 2024 to identify eligible randomized controlled trials (RCTs). Clinical outcomes were evaluated using a random-effects model to pool risk ratios (RRs) with 95% CIs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 17 studies reporting data at different follow-ups for nine trials were included (<jats:italic toggle=\"yes\">n<\/jats:italic>=9092). No statistically significant difference was observed between TAVR and SAVR for reducing all-cause death at 30 days, 1 year, and 2 years but significantly increased risk with TAVR at 5 years or longer follow-up (RR=1.13, 95% CI: 1.03\u20131.23). However, TAVR was associated with a significantly decreased risk for cardiac death at 1-year follow-up (RR=0.79, 95% CI: 0.64\u20130.96) and comparable risk for cardiac death at 30 days, 2 years, and 5 years or longer follow-up when compared with SAVR. No statistically significant difference was observed between TAVR and SAVR for reducing the risk of myocardial infarction (MI) at 30 days, 1 year, 2 years, and 5 years or longer follow-up.<\/jats:p>\n            <jats:p>TAVR was associated with a significantly lower risk of major bleeding events at 30 days (RR=0.38, 95% CI: 0.21\u20130.67); lower risk of acute kidney injury (AKI) at 30 days (RR=0.38, 95% CI: 0.26\u20130.54) and 1 year (RR=0.58, 95% CI: 0.41\u20130.82) and lower risk of new onset or worsening atrial fibrillation (AF) at 30 days (RR=0.25, 95% CI: 0.18\u20130.34), 1 year (RR=0.26, 95% CI: 0.16\u20130.41) and 2 years (RR=0.32, 95% CI: 0.20\u20130.49) when compared with SAVR. However, TAVR was associated with a significantly increased risk of permanent pacemaker implantation (PPI) at 30 days (RR: 2.62, 95% CI: 1.40\u20134.91), at 1 year (RR: 2.19, 95% CI: 1.24\u20133.87), at 2 years (RR: 2.74, 95% CI: 1.31\u20135.71), and beyond 5 years (RR: 1.95, 95% CI: 1.20\u20133.15). TAVR was also associated with a significantly increased risk of prosthetic valve thrombosis at 2 years (RR=2.70, 95% CI: 1.08\u20136.71), though no significant association was observed at 30 days, 1 year, or 5 years. Similarly, no significant differences were observed in aortic-valve reintervention rates at 30 days, 2 years, or 5 years, but TAVR showed a significantly increased risk at 1 year (RR=1.98, 95% CI: 1.21\u20133.24). TAVR was associated with a significantly increased risk of major vascular complications at 30 days (RR=2.37, 95% CI: 1.38\u20134.04) and a significantly increased risk of TIA at 2 years (RR: 1.43, 95% CI: 1.02\u20132.00, <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>=0%). The risk of hospitalizations was comparable between the groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>TAVR and SAVR demonstrated comparable rates of all-cause death up to 2 years of follow-up. However, at 5 years or longer follow-up, TAVR was associated with a higher risk of all-cause death. While TAVR showed certain procedural advantages, such as a lower risk of major bleeding, AKI, and new-onset or worsening AF, the choice between TAVR and SAVR in patients with low or intermediate surgical risk should consider long-term outcomes, with SAVR potentially being more favorable due to better survival observed on longer follow-up durations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/js9.0000000000002158","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T12:01:05Z","timestamp":1731931265000},"page":"8097-8106","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Meta-analysis of longitudinal comparison of transcatheter versus surgical aortic valve replacement in patients at low to intermediate surgical risk"],"prefix":"10.1097","volume":"110","author":[{"given":"Mushood","family":"Ahmed","sequence":"first","affiliation":[{"name":"Rawalpindi Medical University, Rawalpindi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areeba","family":"Ahsan","sequence":"additional","affiliation":[{"name":"Foundation University School of Health Sciences, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimen","family":"Shafiq","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain A.","family":"Nadeem","sequence":"additional","affiliation":[{"name":"Allama Iqbal Medical College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariha","family":"Arif","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeshal","family":"Zulfiqar","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad H.","family":"Kazmi","sequence":"additional","affiliation":[{"name":"Sunderland Royal Hospital, Sunderland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukesh","family":"Yadav","sequence":"additional","affiliation":[{"name":"Maharajgunj Medical Campus, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hritvik","family":"Jain","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences, Jodhpur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheel","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Royal Brompton Hospital, London, UK"},{"name":"National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Alam","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan","family":"Shahid","sequence":"additional","affiliation":[{"name":"Queen Elizabeth Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12]]},"reference":[{"key":"R1-20250824","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet Lond Engl"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","article-title":"Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study","volume":"62","author":"Osnabrugge","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250824","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(09)60211-7","article-title":"Aortic stenosis","volume":"373","author":"Carabello","year":"2009","journal-title":"Lancet Lond Engl"},{"key":"R4-20250824","first-page":"125","article-title":"TAVR and SAVR: current treatment of aortic stenosis","volume":"6","author":"Hu","year":"2012","journal-title":"Clin Med Insights Cardiol"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"e0196877","DOI":"10.1371\/journal.pone.0196877","article-title":"Transcatheter aortic valve implantation for aortic stenosis in high surgical risk patients: a systematic review and meta-analysis","volume":"13","author":"Liu","year":"2018","journal-title":"PloS One"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijcard.2016.10.003","article-title":"A meta-analysis and meta-regression of long-term outcomes of transcatheter versus surgical aortic valve replacement for severe aortic stenosis","volume":"225","author":"Villablanca","year":"2016","journal-title":"Int J Cardiol"},{"key":"R7-20250824","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/eurheartj\/ehz275","article-title":"Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis","volume":"40","author":"Siontis","year":"2019","journal-title":"Eur Heart J"},{"key":"R8-20250824","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMoa2400685","article-title":"Transcatheter or surgical treatment of aortic-valve stenosis","volume":"390","author":"Blankenberg","year":"2024","journal-title":"N Engl J Med"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1093\/eurheartj\/ehae331","article-title":"Transcatheter aortic valve implantation in low-risk tricuspid or bicuspid aortic stenosis: the NOTION-2 trial","volume":"45","author":"J\u00f8rgensen","year":"2024","journal-title":"Eur Heart J"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R13-20250824","doi-asserted-by":"crossref","first-page":"e24306","DOI":"10.1002\/clc.24306","article-title":"Temporal trends in the outcomes of percutaneous coronary intervention with zotarolimus eluting stents versus everolimus eluting stents: a meta-analysis of randomized controlled trials","volume":"47","author":"Basit","year":"2024","journal-title":"Clin Cardiol"},{"key":"R14-20250824","first-page":"101405","article-title":"Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention: a meta-analysis of randomized controlled trials","volume":"52","author":"Ahmed","year":"2024","journal-title":"Int J Cardiol Heart Vasc"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.5114\/amsad\/188269","article-title":"Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in patients with unprotected left main coronary artery disease: a systematic review and meta-analysis of randomized controlled trials and propensity score-matched studies","volume":"9","author":"Ahmed","year":"2024","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"R18-20250824","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R19-20250824","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.jacc.2015.03.014","article-title":"Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial","volume":"65","author":"Thyregod","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R20-20250824","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"key":"R21-20250824","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"key":"R22-20250824","first-page":"383","article-title":"A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial","volume":"8","author":"Nielsen","year":"2012","journal-title":"EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol"},{"key":"R23-20250824","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"R24-20250824","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1001\/jama.2022.5776","article-title":"Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial","volume":"327","author":"Toff","year":"2022","journal-title":"JAMA"},{"key":"R25-20250824","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"key":"R26-20250824","doi-asserted-by":"crossref","first-page":"e003665","DOI":"10.1161\/CIRCINTERVENTIONS.115.003665","article-title":"Two-year outcomes in patients with severe aortic valve stenosis randomized to transcatheter versus surgical aortic valve replacement: the all-comers nordic aortic valve intervention randomized clinical trial","volume":"9","author":"S\u00f8ndergaard","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"R27-20250824","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/eurheartj\/ehae043","article-title":"Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial","volume":"45","author":"Thyregod","year":"2024","journal-title":"Eur Heart J"},{"key":"R28-20250824","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jacc.2021.11.062","article-title":"2-year outcomes after transcatheter versus surgical aortic valve replacement in low-risk patients","volume":"79","author":"Forrest","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R29-20250824","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcin.2019.10.043","article-title":"Complete 2-year results confirm bayesian analysis of the SURTAVI trial","volume":"13","author":"Van Mieghem","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"R30-20250824","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jamacardio.2022.2695","article-title":"Self-expanding transcatheter vs surgical aortic valve replacement in intermediate-risk patients: 5-year outcomes of the SURTAVI randomized clinical trial","volume":"7","author":"Van Mieghem","year":"2022","journal-title":"JAMA Cardiol"},{"key":"R31-20250824","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1910555","article-title":"Five-year outcomes of transcatheter or surgical aortic-valve replacement","volume":"382","author":"Makkar","year":"2020","journal-title":"N Engl J Med"},{"key":"R32-20250824","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2020.12.052","article-title":"Outcomes 2 years after transcatheter aortic valve replacement in patients at low surgical risk","volume":"77","author":"Leon","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R33-20250824","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMoa2307447","article-title":"Transcatheter aortic-valve replacement in low-risk patients at five years","volume":"389","author":"Mack","year":"2023","journal-title":"N Engl J Med"},{"key":"R34-20250824","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/clc.23454","article-title":"Transcatheter vs surgical aortic valve replacement in low to intermediate surgical risk aortic stenosis patients: a systematic review and meta-analysis of randomized controlled trials","volume":"43","author":"Zhang","year":"2020","journal-title":"Clin Cardiol"},{"key":"R35-20250824","first-page":"1171","article-title":"Transcatheter vs surgical aortic valve replacement for aortic stenosis in low-intermediate risk patients: a meta-analysis","volume":"33","author":"Tam","year":"2017","journal-title":"Can J Cardiol"},{"key":"R36-20250824","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.athoracsur.2023.10.006","article-title":"Survival after surgical aortic valve replacement in low-risk patients: a contemporary trial benchmark","volume":"117","author":"Thourani","year":"2024","journal-title":"Ann Thorac Surg"},{"key":"R37-20250824","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1093\/eurheartj\/ehab375","article-title":"Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement","volume":"42","author":"J\u00f8rgensen","year":"2021","journal-title":"Eur Heart J"},{"key":"R38-20250824","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1161\/CIRCULATIONAHA.118.036606","article-title":"Five-year clinical and echocardiographic outcomes from the NOTION randomized clinical trial in patients at lower surgical risk","volume":"139","author":"Thyregod","year":"2019","journal-title":"Circulation"},{"key":"R39-20250824","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMoa2307447","article-title":"Transcatheter aortic-valve replacement in low-risk patients at five years","volume":"389","author":"Mack Michael","year":"2023","journal-title":"N Engl J Med"},{"key":"R40-20250824","first-page":"466","article-title":"Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement","volume":"88","author":"Bocksch","year":"2016","journal-title":"Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv"},{"key":"R41-20250824","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.amjcard.2014.07.019","article-title":"Comparison of hemodynamic performance of the balloon-expandable SAPIEN 3 versus SAPIEN XT transcatheter valve","volume":"114","author":"Amat-Santos","year":"2014","journal-title":"Am J Cardiol"},{"key":"R42-20250824","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jcin.2012.09.019","article-title":"Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve","volume":"6","author":"Binder","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"R43-20250824","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jacc.2013.10.058","article-title":"Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve)","volume":"63","author":"G\u00e9n\u00e9reux","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R44-20250824","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.kint.2016.11.030","article-title":"Endovascular aneurysm repair (EVAR)\u2013 and transcatheter aortic valve replacement (TAVR)\u2013associated acute kidney injury","volume":"91","author":"Jhaveri","year":"2017","journal-title":"Kidney Int"},{"key":"R45-20250824","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.athoracsur.2011.08.078","article-title":"Postprocedural atrial fibrillation after transcatheter aortic valve implantation versus surgical aortic valve replacement","volume":"93","author":"Motloch","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"R46-20250824","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/eurheartj\/ehad387","article-title":"Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock","volume":"44","author":"Goel","year":"2023","journal-title":"Eur Heart J"},{"key":"R47-20250824","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.amjcard.2016.07.045","article-title":"Frequency and effect of access-related vascular injury and subsequent vascular intervention after transcatheter aortic valve replacement","volume":"118","author":"Dencker","year":"2016","journal-title":"Am J Cardiol"},{"key":"R49-20250824","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1111\/jocs.15363","article-title":"Pacemaker following transcatheter aortic valve replacement and tricuspid regurgitation: a single-center experience","volume":"37","author":"Nona","year":"2022","journal-title":"J Card Surg"},{"key":"R50-20250824","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jcin.2023.12.034","article-title":"Pacemaker implantation rate following TAVR: from registries to standard of care","volume":"17","author":"Philippon","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"R51-20250824","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/jce.16185","article-title":"Post-TAVR conduction abnormalities leading to permanent pacemaker implantation: risk factors, prevention, and management","volume":"35","author":"Ghazal","year":"2024","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:18:42Z","timestamp":1756063122000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002158","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"2024-07-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}